CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biopharmaceutical company, announced today that Dr. Spyridon "Spyros" Papapetropoulos has joined as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Papapetropoulos will lead Cavion’s research and development organization to advance therapies based on the company’s T-type calcium channel (Cav3) platform.Read More
C-VILLE Weekly is Charlottesville's leading newspaper. Founded in 1989, it's been the area's local source for informative stories in news, arts and living for over 25 years. C-VILLE Weekly reaches 60,000+ readers with 23,000 weekly copies and a website that averages over 15,000 visitors per week.
This is the link - http://www.c-ville.com/work-
Equal Employment Opportunity C-VILLE Weekly is committed to being an equal opportunity employer and makes all employment-related decisions based on job-related criteria only. This means that C-VILLE Weekly does not discriminate and will not allow discrimination based on race, color, national origin, religion, sex (gender), sexual orientation, age, disability, marital status, veteran status, and/or any other legally protected status. Our policy of equal employment opportunity applies to applicants, current staff members, and past employees. It applies to all aspects of the employment relationship, including but not limited to applications and initial employment, promotions and transfers, demotions, termination, compensation and benefits, and training opportunities.
Individuals with Disabilities Regarding equal employment, please note that C-VILLE Weekly strongly supports the policies contained in the rehabilitation Act of 1973, the Vietnam Veteran’s Readjustment Assistance Act of 1974, the Americans with Disabilities Act of 1990 (ADA), and other state and federal laws on the subject of disabilities in the workplace setting.